Organization
Bakersfield Dermatology, Bakersfield, United States
2 abstracts
Abstract
APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR: IMPROVEMENTS IN NAIL AND SCALP PSORIASIS AND PSORIASIS AREA AND SEVERITY INDEX IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS (ESTEEM 1 AND 2) Org: Probity Medical Research, Waterloo, Canada, Bakersfield Dermatology, Bakersfield, United States, Toulouse University, Hôpital Larrey, Toulouse, France, SKiN Centre for Dermatology, Peterborough, Canada, SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany,
Abstract
APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS INCLUDING CURRENT SKIN INVOLVEMENT: RESULTS OF A PHASE 3, RANDOMIZED, CONTROLLED TRIAL Org: University of Massachusetts Medical School, Worcester, United States, INIBIC-Hospital Universitario A Coruña, Galicia, Spain, Bakersfield Dermatology, Bakersfield, United States, Celgene Corporation, Warren, United States, University Hospital Southampton, Southampton, United Kingdom,